Aluisio Cotrim Segurado

Dr. Aluisio Cotrim Segurado

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2004 in AIDS Patient Care and STDs
Verified
Journal Article
Closed access
ASAluisio Cotrim Segurado
Aluisio Cotrim Segurado
PBPatrícia Braga
Patrícia Braga
AEArnaldo Etzel
Arnaldo Etzel
MCMaria Regina Alves Cardoso
Maria Regina Alves Cardoso
Although HIV/hepatitis C virus (HCV) coinfection has been recognized worldwide in individuals exposed to blood-borne and sexually transmitted diseases (STD), limited data are available on the epidemiology of this coinfection in Brazil. A cross-sectional study was carried out to estimate the prevalence of HCV seropositivity in a cohort of people living with HIV/AIDS in Santos, Brazil, and to investigate potential risk factors for HCV infection. Anti-HCV antibodies were sought by using two immunoenzymatic assays. Overall HCV seroprevalence was 36.2% (95% confidence interval [CI] 31.9-40.4%). However, it was significantly higher (84.8%, 95% CI 78.2-91.3%) among intravenous drug users (IDU) as compared to non-IDU (20.9%, 95% CI 16.8-25.1%) (p < 0.001). Multiple logistic regression analysis revealed that HCV seropositivity among IDU was independently associated with needle sharing (adjusted odds ratio [adjOR] = 4.28, p = 0.07) and with serologic evidence of exposure to other bloodborne agents: HBV (adjOR = 4.39, p = 0.01) and HTLV-I/II (adjOR = 6.43, p = 0.02). In contrast, no association with lifetime number of sexual partners, history of STD, or of sex with commercial sex workers (CSW) could be demonstrated. Among non-IDU, HCV seropositivity was independently associated with sexual partnership with IDU (adjOR = 2.15, p = 0.08) and with HBV seropositivity (adjOR = 1.71, p = 0.05), but not with engaging in oral or anal receptive intercourse or having sex with CSW. Results indicate that exposure to blood and sexual partnership with IDU constitute the main risk factors for HCV acquisition among HIV-positive patients in Santos, Brazil. Prevention of HCV spread in this population should thus include harm reduction measures and information on safer sex practices for both IDU and their sexual partners.

1 January 2007 in Reproductive Health Matters
Verified
Journal Article
Closed access
PDF file
ASAluisio Cotrim Segurado
Aluisio Cotrim Segurado
VPVera Paiva
Vera Paiva
En muchas regiones del mundo, la mayoría de las infecciones por VIH son transmitidas sexualmente o en asociación con el embarazo, el parto o la lactancia, por lo cual es esencial que las iniciativas de salud sexual y reproductiva y VIH/SIDA se refuercen mutuamente. Muchas personas que viven con VIH y que gozan de buena salud van a querer hijos. Una terapia antirretroviral muy activa les brinda a las personas que viven con SIDA la posibilidad de concebir nuevos proyectos de vida, como la paternidad, una vez recobran su salud. Sin embargo, aún deben tomar decisiones difíciles respecto a la sexualidad, los deseos de paternidad y la vida en familia. Los aspectos estructurales, sociales y culturales, así como la falta de apoyo programático, obstruyen el goce del derecho a servicios de salud sexual y reproductiva de calidad y el apoyo para tener una familia. Este artículo trata sobre el continuo de atención implicada en la paternidad de las personas seropositivas, desde el embarazo hasta los cuidados de bebés y niños, y expone ejemplos basados en evidencia de políticas y programas que integran las intervenciones de salud sexual y reproductiva a la atención del VIH/SIDA a fin de apoyar la paternidad. El centrarse en la paternidad de las personas que viven con VIH y son afectadas por éste, es decir, centrarse en la pareja y no en la mujer como la unidad de cuidados, la persona o la pareja de adultos responsables de criar a los hijos, sería un avance programático innovador. El trascender la atención a la salud materno-infantil para proporcionar cuidados y apoyo a los padres y otros responsables de criar a los niños es especialmente pertinente para las personas que viven con infección por VIH.

28 May 2022 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Open access
PDF file
RDRodolfo Damiano
Rodolfo Damiano
DNDeusdedit Brandão Neto
Deusdedit Brandão Neto
JOJoão Vitor Ribeiro Oliveira
João Vitor Ribeiro Oliveira
JSJonatas Magalhães Santos
Jonatas Magalhães Santos
JAJulia Vallin Rodrigues Alves
Julia Vallin Rodrigues Alves
SCSilvia Figueiredo Costa
Silvia Figueiredo Costa
Preliminary methodologically limited studies suggested that taste and smell known as chemosensory impairments and neuropsychiatric symptoms are associated in post-COVID-19. The objective of this study is to evaluate whether chemosensory dysfunction and neuropsychiatric impairments in a well-characterized post-COVID-19 sample. This is a cohort study assessing adult patients hospitalized due to moderate or severe forms of COVID-19 between March and August 2020. Baseline information includes several clinical and hospitalization data. Further evaluations were made using several different reliable instruments designed to assess taste and smell functions, parosmia, and neuropsychiatric disorders (using standardized psychiatric and cognitive measures). Out of 1800 eligible individuals, 701 volunteers were assessed on this study. After multivariate analysis, patients reporting parosmia had a worse perception of memory performance (p < 0.001). Moderate/severe hypogeusia was significantly associated with a worse performance on the word list memory task (p = 0.012); Concomitant moderate/severe olfactory and gustatory loss during the acute phase of COVID-19 was also significantly associated with episodic memory impairment (p = 0.006). We found a positive association between reported chemosensory (taste and olfaction) abnormalities and cognition dysfunction in post-COVID-19 patients. These findings may help us identify potential mechanisms linking these two neurobiological functions, and also support the speculation on a possible route through which SARS-CoV-2 may reach the central nervous system.

1 November 2020 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
BPBeatriz Perondi
Beatriz Perondi
AMAnna Miethke-Morais
Anna Miethke-Morais
AMAmanda C. Montal
Amanda C. Montal
LHLeila Harima
Leila Harima
ASAluisio Cotrim Segurado
Aluisio Cotrim Segurado
As of August 30, 2020, Brazil ranked second among countries with the highest number of COVID-19 cases, with the city of São Paulo as the national epidemic epicenter. Local public healthcare institutions were challenged to respond to a fast-growing hospital demand, reengineering care provision to optimize clinical outcomes and minimize intra-hospital coronavirus infection. In this paper we describe how the largest public hospital complex in Latin America faced this unprecedented burden, managing severe COVID-19 cases while sustaining specialized care to patients with other conditions. In our strategic plan a 900-bed hospital was exclusively designated for COVID-19 care and continuity of care to those not infected with coronavirus ensured in other inpatient facilities. After 152 days, 4241 patients with severe COVID-19 were hospitalized, 70% of whom have already been discharged, whereas the remaining Institutes of the complex successfully maintained high complexity inpatient and urgent/emergency care to non-COVID-19 patients.

5 February 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
Larissa Melo BandeiraLarissa Melo Bandeira
Larissa Melo Bandeira
MPMarco Antonio Moreira Puga
Marco Antonio Moreira Puga
SWSabrina Weis-Torres
Sabrina Weis-Torres
GRGrazielli R. Rezende
Grazielli R. Rezende
JDJoão A. Domingos
João A. Domingos
ACAna Rita Coimbra Coimbra Motta de Castro
Ana Rita Coimbra Coimbra Motta de Castro
Human T-cell leukemia virus type 1 (HTLV-1) has worldwide distribution and is considered endemic in southwestern Japan. HTLV-1 infection has been associated with adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) besides other diseases. This cross-sectional study aimed to investigate the prevalence, risk factors and molecular characterization of HTLV-1, among the world’s largest population of Japanese immigrants and their descendants outside of Japan, in São Paulo, Southeast Brazil, as well as to analyze the phylogenetic relationship among isolates of HTLV-1. From July to December 2017, 2,139 individuals from five Japanese associations were interviewed and submitted to blood collection. All serum samples were first tested for the presence of anti-HTLV-1/2 antibodies by ELISA and then peripheral blood from individuals with positive serological results were analyzed for the presence of HTLV-1 5’LTR proviral DNA. Partial sequencing of the 5’LTR region of HTLV-1 proviral DNA was performed by Sanger. The prevalence of HTLV-1 infection was 5.1% (CI 95%: 4.2–6.0). In the multiple logistic regression model, HTLV-1 infection was associated with age ≥ 45 years, female sex, being first and second-generation Japanese immigrants, and having sexual partners with history of blood transfusion. The phylogenetic analysis revealed that all HTLV-1 were classified as Cosmopolitan (1a) subtype. Of them, 47.8% were classified as Transcontinental (A) subgroup and 52.2% as belonging to the Japanese (B) subgroup. Although most HTLV-1-infected patients were asymptomatic (97.3%), blurred vision was associated with HTLV-1 infection. The high prevalence of HTLV-1 infection found in this studied population and especially the intra- and interfamily HTLV-1 transmission presents an urgent call for preventive and control responses of this infection in Brazil.

16 September 2021 in Journal of Infection
Verified
Journal Article
Closed access
ALAlessandra Luna-Muschi
Alessandra Luna-Muschi
IBIgor Carmo Borges
Igor Carmo Borges
EFElizabeth de Faria
Elizabeth de Faria
ABAntonio S. Barboza
Antonio S. Barboza
FMFernando L. Maia
Fernando L. Maia
SCSilvia Figueiredo Costa
Silvia Figueiredo Costa